Literature DB >> 19513897

Expression and functional roles of Smad1 and BMPR-IB in glioma development.

Shuang Liu1, Zengmin Tian, Feng Yin, Peng Zhang, Yanrui W, Xuefeng Ding, Haitao Wu, Yan Wu, Xiaozhong Peng, Jiangang Yuan, Boqin Qiang, Wenhong Fan, Ming Fan.   

Abstract

Here we report the negative correlation of phosphorylation of Smad1 and BMPR-IB expression with the development of human glioma. Western blot analysis showed that expression of both phospho-Smad1/5/8 and BMPR-IB were decreased in malignant glioma tissues compared with normal brain tissues. Kaplan-Meier survival curves revealed that lower expression ratio of phospho-Smad1/5/8 to Smad1 expression significantly correlates with poor patient survival. Transient transfection of BMPR-IB activates Smad1 signaling and induces differentiation and apoptosis of U251 and U87 glioblastoma cells. The effects could be blocked by cotransfection of Smad6. These results might provide new molecular marker and target for glioma diagnosis and therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19513897     DOI: 10.1080/07357900802620786

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  8 in total

1.  Genomic imbalances in esophageal carcinoma cell lines involve Wnt pathway genes.

Authors:  Jacqueline Brown; Hannelie Bothma; Robin Veale; Pascale Willem
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

2.  Over-expression of BMPR-IB reduces the malignancy of glioblastoma cells by upregulation of p21 and p27Kip1.

Authors:  Shuang Liu; Feng Yin; Wenhong Fan; Shuwei Wang; Xin-ru Guo; Jian-ning Zhang; Zeng-min Tian; Ming Fan
Journal:  J Exp Clin Cancer Res       Date:  2012-05-31

3.  Genomic Analysis of the BMP Family in Glioblastomas.

Authors:  Laura D Hover; Ty W Abel; Philip Owens
Journal:  Transl Oncogenomics       Date:  2015-04-15

4.  BMPR1B up-regulation via a miRNA binding site variation defines endometriosis susceptibility and CA125 levels.

Authors:  Cherry Yin-Yi Chang; Yi Chen; Ming-Tsung Lai; Hui-Wen Chang; Jack Cheng; Carmen Chan; Chih-Mei Chen; Shan-Chih Lee; Ying-Ju Lin; Lei Wan; Pei-Wen Tsai; Su-Han Yang; Ching Chung; Jim Jinn-Chyuan Sheu; Fuu-Jen Tsai
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

5.  The homing and inhibiting effects of hNSCs-BMP4 on human glioma stem cells.

Authors:  Shuang Liu; Feng Yin; Mingming Zhao; Chunhui Zhou; Junlin Ren; Qiming Huang; Zhongming Zhao; Ramkrishna Mitra; Wenhong Fan; Ming Fan
Journal:  Oncotarget       Date:  2016-04-05

Review 6.  Therapeutic Potential for Bone Morphogenetic Protein 4 in Human Malignant Glioma.

Authors:  Guifa Xi; Benjamin Best; Barbara Mania-Farnell; Charles David James; Tadanori Tomita
Journal:  Neoplasia       Date:  2017-03-07       Impact factor: 5.715

7.  [cDNA microarray technique on screening multi-drug resistance-related genes of human non-small cell lung cancer].

Authors:  Meiyan Liu; Chunhong Li; An Yan; Li Cai
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-04

Review 8.  BMPs as therapeutic targets and biomarkers in astrocytic glioma.

Authors:  Pilar González-Gómez; Nilson Praia Anselmo; Helena Mira
Journal:  Biomed Res Int       Date:  2014-04-28       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.